A new clinical trial gives providers objective, measured evidence on DAO Botox® injection technique and its effect on lower-face muscle balance. The findings show why new injectors need to think beyond the patient’s stated concern to guide both the treatment and the result.
Home›Training›Botox® Training for Physician Assistants For Physician Assistants (PA-C) Botox® Training for Physician Assistants ★★★★★ 4.9 / 5 · 6,359 verified reviews IAPAM’s Botox® training
Home›Training›Botox® Training for Nurse Practitioners For Nurse Practitioners (NPs) Botox® Training for Nurse Practitioners ★★★★★ 4.9 / 5 · 6,359 verified reviews IAPAM’s Botox® training
June’s clinical evidence points to a more disciplined approach to combination care: select and sequence treatment based on anatomy, evidence quality, recovery burden, and the patient’s changing trajectory. This update examines new data on skin-quality injectables, radiofrequency microneedling, and regenerative approaches to help aesthetic providers build safer, more individualized plans.
Cosmetic Injectables Certification (including Botox®) & PRP for Aesthetics Training Bundle Three courses in one easy-to-follow online training bundle! START TRAINING NOW Cosmetic Injectables Certification
Aesthetic Medicine Training & Certification Accelerate your practice with the industry’s leading aesthetic medicine training for Physicians, Nurse Practitioners, and Physician Assistants. For hands-on training
Botox® resistance has identifiable triggers and formulation-level solutions. Here’s what aesthetic providers need to know about immunogenicity and management.
Setting prices for aesthetic treatments is different from billing insurance. Here’s a practical framework for benchmarking your market and building a fee structure that’s profitable.
A 2026 single-center observational study reports preliminary evidence that botulinum toxin may be deliverable transdermally for sebum reduction in oily and acne-prone skin. Here’s what the early data shows and what providers should watch for.
The May 2026 aesthetic medicine update covers a neurotoxin pipeline producing genuinely new options and a patient population that is outgrowing the standard consult model. Providers who act on this month’s clinical and business signals — from GLP-1 protocol updates to the growing male aesthetic market — will be better positioned heading into the second half of 2026.